Pfizer asks FDA for a product-specific guidance on demonstrating bioequivalence to its Estring vaginal ring.
FDA says that Organogenesis has not submitted a required pediatric study for its Gintuit allogenic oral soft tissue product.
FDA approves changes to labeling for Gileads Odefsey to add 48-week data from trials in which subjects switched to Odefsey from either Complera or Atr...
FDA tells Cardiome Pharma that a data package proposed by the company would not be sufficient to support a resubmission of its NDA for Brinavess(verna...
Federal Register notice: FDA establishes a public docket to assist with its development of recommendations on the communication of risk information in...
FDA says it will revise a draft guidance on submission of facility information for expedited priority ANDA reviews in response to changes in the lates...
FDA recognizes UL 2900-1 as a medical device cybersecurity standard.
FDAs Office of Pediatric Therapeutics announces a 9/18-19 public workshop entitled Advancing the Development of Pediatric Therapeutics (ADEPT): Applic...